Conor McNamara
Stock Analyst at RBC Capital
(0)
# 4392
Out of 5,218 analysts
92
Total ratings
29.33%
Success rate
-10.27%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Bio-Rad Laboratories | Maintains: Outperform | 369 481 | 335.94 | 43.18% | 9 | Dec 9, 2024 | |
Maravai LifeSciences | Maintains: Outperform | 17 13 | 5.67 | 129.28% | 6 | Nov 8, 2024 | |
Hologic | Maintains: Sector Perform | 86 89 | 73.64 | 20.86% | 8 | Nov 5, 2024 | |
Illumina | Maintains: Outperform | 252 254 | 143.9 | 76.51% | 12 | Nov 5, 2024 | |
Thermo Fisher Scient... | Maintains: Outperform | 767 718 | 527.13 | 36.21% | 13 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 333 311 | 235.01 | 32.33% | 7 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 205 205 | 156.26 | 31.19% | 9 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 34 34 | 22.32 | 52.33% | 5 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 61 | 41.37 | 47.45% | 10 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 7 7 | 3.8 | 84.21% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Perform | 72 70 | 75.59 | -7.4% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 3.27 | 114.07% | 4 | Aug 7, 2024 |